Highlights from day two of the European Stroke Organisation Conference 2018
Published date:
The second day of the European Stroke Organisation Conference 2018 highlighted the value of collaborations between professional societies and patient representatives for the advancement of stroke care.
New clot-busting treatment option for ‘wake-up’ stroke patients
Published date:
Presented today at the European Stroke Organisation Conference in Gothenburg, the results of the international WAKE-UP trial suggest that thousands of people who wake up with a stroke each year in the UK could now benefit from life-changing thrombolysis treatment.
Highlights from day one of the European Stroke Organisation Conference 2018
Published date:
The European Stroke Organisation Conference (ESOC) 2018 is currently on from 16-18 May in Gothenburg, Sweden. The first day of ESOC included some truly inspiring scientific sessions, including the WAKE-UP trial, RIGHT-2 trial and CROMIS-2 trials.
New research suggests brain scans could help predict brain bleed risk in patients on anticoagulant drugs.
Published date:
The CROMIS-2 study investigated whether signs of small brain bleeds on routine brain scans can help us understand which ischaemic stroke patients with atrial fibrillation are at increased risk of a bleed in the brain when on anticoagulant ‘blood thinning’ drugs.
New research suggests that a drug used to treat bleeding could benefit some stroke patients
Published date:
Led by the University of Nottingham, a new international study investigated whether patients with a spontaneous bleed in the brain (intracerebral haemorrhage) could benefit from this drug, if delivered as an emergency treatment. An intracerebral haemorrhage is a type of stroke.